A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.
Some experts stated the demand for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer laws, risking fines, legal action or imprisonment.
Service Reaction and Content Removal
Based on the social media company, the platform has removed violative material and banned associated keywords and query recommendations. The organization stated it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Trading Operations
Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or injecting at home.
Within moments of entering one group, a seller posted contact information, where most transactions take place. The vendor provided an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Item Details and Pricing
Within these communities, messages show dark colored packages with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram stated it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has already seen patients injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially serious health risks”.
